Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
US7615570B2 · kind B2 · utility
3Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2005 |
| Grant date | Nov 10, 2009 |
| Priority date | — |
| Expiry date | Oct 15, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having formula (I)or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein L, A, G, R1, R2 and R3 are as defined herein. These compounds are particularly useful in the treatment of pain, inflammatory hyperalgesia, and urinary dysfunctions, such as bladder overactivity and urinary incontinence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.